Shares in Ocular Therapeutix (NSDQ:OCUL) fell today after the ophthalmologic device developer posted 1st quarter earnings that missed expectations on Wall Street.
The Bedford, Mass.-based company posted losses of $16 million, or 58¢ per share, on sales of $475,000 for the 3 months ended March 31, seeing losses grow 47.8% while sales grew 14.2% compared with the same period last year.
Read the whole story on our sister site, Drug Delivery Business
The post Ocular Therapeutix shares fall on Q1 miss appeared first on MassDevice.
from MassDevice http://ift.tt/2qBqe13
Cap comentari:
Publica un comentari a l'entrada